Celebrex GI Safety, Warfarin Claims Over Vioxx Need Corrective Letter - FDA

Pharmacia should issue a Celebrex "Dear Healthcare Provider Letter" to correct violative safety information disseminated about the COX-2 inhibitor during an audioconference series and in two professional sales pieces, a Feb. 1 FDA warning letter states.